Screening for celiac disease in asymptomatic children with down syndrome: Cost-effectiveness of preventing lymphoma

Pediatrics

Volumn 118, Issue 2, 2006, Pages 816-817

  Kawatu, David ^a   LeLeiko, Neal S ^a,b  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER STAGING; CELIAC DISEASE; CHILD; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DOWN SYNDROME; GLUTEN FREE DIET; GROWTH RETARDATION; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOMA; MEDICAL SOCIETY; NONHODGKIN LYMPHOMA; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; SCREENING TEST; SYMPTOMATOLOGY; UNITED STATES; COST BENEFIT ANALYSIS; DISEASE PREDISPOSITION; ECONOMICS; GASTROINTESTINAL TUMOR; GROWTH DISORDER; LIFE EXPECTANCY; MASS SCREENING; PREVALENCE;

CELIAC DISEASE; CHILD; COST-BENEFIT ANALYSIS; DISEASE SUSCEPTIBILITY; DOWN SYNDROME; GASTROINTESTINAL NEOPLASMS; GROWTH DISORDERS; HUMANS; LIFE EXPECTANCY; LYMPHOMA, NON-HODGKIN; MASS SCREENING; PREVALENCE;

EID: 33748415087     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1194     Document Type: Note

References (9)

1. Hill ID, Dirks MH, Liptak GS, et al. Guidelines for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1-19
2. Aschengrau A, Seage GR. Essentials of Epidemiology and Public Health. Sudbury, MA: Jones and Bartlett Publishers, Inc; 2003
3. Green PHR, Jabri B. Celiac disease and other precursors to small-bowel malignancy. Hematol Oncol Clin North Am. 2003;17:611-624
4. Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am J Med. 2003;115:191-195
5. Shamir R. Advances in celiac disease. Gastroenterol Clin North Am. 2003;32:931-947
6. Swigonski NL, Kuhlenschmidt HL, Bull MJ, Corkins MR, Downs SM. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma. Pediatrics. 2006;118:594-602
7. Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol. 2004;46:282-286
8. Freemark M, Levitsky LL. Screening for celiac disease in children with type 1 diabetes: two views of controversy. Diabetes Care. 2003;26:1932-1939
9. Rami B, Sumnik Z, Schober E, et al. Screening detected celiac disease in children with type 1 diabetes mellitus: effect on the clinical course (a case control study). J Pediatr Gastroenterol Nutr. 2005;41:317-321